Press Releases :: Nighthawk Biosciences, Inc. (NHWK)

May 19, 2021 7:30am EDT

Heat Biologics Announces Multiple Presentations on PTX-35 at the Upcoming 3rd Annual Treg Directed Therapies Summit

May 10, 2021 7:30am EDT

Heat Biologics Appoints Anthony Manning, Ph.D. as Chief Scientific Advisor

May 05, 2021 7:30am EDT

Heat Biologics Provides First Quarter 2021 Business Update; Reports Continued Progress on Oncology and COVID-19 Vaccine Programs

Apr 12, 2021 7:30am EDT

Heat Biologics Announces New Preclinical Data on PTX-35, Demonstrating Decreased Regulatory T-cell (Treg) Activity and Delayed Tumor Progression at American Association for Cancer Research (AACR) Annual Meeting 2021

Mar 25, 2021 9:00am EDT

Heat Biologics Provides Year-End Business Update

Mar 08, 2021 7:30am EST

Heat Biologics to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

Feb 12, 2021 3:00pm EST

Heat Biologics to Present at 2021 BIO CEO & Investor Digital Conference

Feb 09, 2021 7:30am EST

Heat Biologics Announces Positive Interim Survival Data from Ongoing HS-110 Phase 2 Non-Small Cell Lung Cancer Trial

Jan 27, 2021 7:30am EST

Heat Biologics Announces Publication of Additional Preclinical COVID-19 Vaccine Results

Jan 20, 2021 7:30am EST

Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021

rss_feed News RSS

OUR ECOSYSTEM